News briefing: Gilead submits filgotinib to European regulators for UC; GW Pharmaceuticals launches PhIII trial for MS candidate made with cannabis extracts - Endpoints News

News briefing: Gilead submits filgotinib to European regulators for UC; GW Pharmaceuticals launches PhIII trial for MS candidate made with cannabis extracts  Endpoints News

Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases